To decipher the role of DENND10 in breast cancer cells, we knocked out the Dennd10 gene in 4T1 cells, a highly metastatic triple-negative breast cancer cell line, using lentivirus-based CRISPR/Cas9 gene editing. The gene discussed is DENND10; the disease is triple-negative breast carcinoma.